Navigation Links
Amedica Announces New Product Offering
Date:11/10/2009

SALT LAKE CITY, Nov. 10 /PRNewswire/ -- Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride ceramic technologies, announced today the launch of four new product offerings. The new product additions are: The Valeo(®) OL VBR, Valeo(®) C VBR, Valeo(®) Concise Cervical Plating System and Valeo(®) BP Synthetic Bone Putty.

As the North American Spine Society (NASS) prepares to meet in San Francisco this week, Amedica prepares to showcase and launch the latest additions to the MC(2)(TM) Silicon Nitride offering of spinal implants, a new cervical plating system and its new beta-TCP bone putty.

Amedica, with the Valeo OL, offers the surgeon yet another option for lumbar spine repair. The Valeo OL couples Amedica's successful hydrophilic thin-walled textured surface with a bulleted nose designed to ease insertion and inferior/superior knurls to guard against migration. The Valeo C exhibits new, improved design features that enhance placement and superior imaging characteristics. The implant also has an enhanced textured surface to encourage bony attachment.

"We continue to be pleased with the acceptance and success of the Valeo Silicon Nitride implants. With the launch of these new products, the new MC(2) Silicon Nitride additions, an exceptional Concise Cervical Plating System and a truly unique beta-TCP bone putty, we continue to demonstrate Amedica's commitment to improving cost-effective patient care," says Ben Shappley, CEO, President & Director.

About Amedica:

Amedica Corporation is ISO 13485 certified and its products are CE approved. Amedica Corporation is an emerging orthopaedic implant company focused on using its silicon nitride ceramic technologies to develop and commercialize a broad range of innovative, unique spine and total joint implants for the growing orthopaedic device market. It has brought to
'/>"/>

SOURCE Amedica Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amedica Receives CE Mark for Valeo(TM) Ceramic Spinal Implant System Incorporating CSC Technology
2. Amedica Receives FDA 510(k) Clearance for Valeo(TM) Pedicle Screw System
3. Amedica Receives FDA 510(k) Clearance for Valeo(TM) Cervical Plate
4. Genoptix Announces Participation at Lazard Capital Management 6th Annual Healthcare Conference
5. China Medicine Announces Conference Call to Discuss Third Quarter 2009 Results
6. Harvest Technologies Announces Completion of Patient Enrollment in its Randomized, Controlled, Double Blind Multicenter IDE Non-Reconstructable Critical Limb Ischemia Trial
7. Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results
8. OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock
9. SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS
10. Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas
11. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
(Date:12/15/2014)... , Dec. 15, 2014 Organovo ... biology company focused on delivering breakthrough 3D bioprinting ... industry and collaborators of its exVive3D TM ... widely available in full commercial release on November ... field, resulting in several awards for innovation. ...
(Date:12/13/2014)... MaRS and Virgin Unite Canada, the non-profit foundation of the ... support Canadian entrepreneurs tackling social and environmental challenges. Today, Sir ... MaRS Centre to announce the new partnership, which includes the ... has $1 million in seed capital provided by Virgin Unite ... Innovation Foundation, founded by Alison Lawton . ...
(Date:12/13/2014)... According to population studies: “North Carolina ... and 2030." If a population explosion like that actually ... state in the country. , To that end, North ... of North Carolina Forum on December 16th to ask ... necessary infrastructure in place? Enough clean water? And will ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2
... as Lead Epidemiologist, RALEIGH, N.C., Oct. 27 ... today the appointment of Dr.,Jerome Wilson as Senior ... Epidemiologist, Dr. Wilson is responsible for providing consulting,services ... PRA provides extensive Phase IV Post-Marketing services to,pharmaceutical ...
... October 27 Stallergenes has,just obtained authorization (IND(1)) from ... in the United States with Oralair(R) Grasses in,the treatment ... The aim of the study, which will be conducted ... to confirm the efficacy and good,tolerance of the product ...
... Beckman,Coulter, Inc. (NYSE: BEC ), a ... simplify, automate, and innovate complex biomedical,testing, announced ... and chief executive officer, will present at ... 4, 2008 at 1:20 p.m.,(ET)., (Logo: ...
Cached Biology Technology:Jerome Wilson Joins PRA International's Late Phase Service Group 2Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009 2Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009 3
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 16, 2014 ... has licensed its PerformTek biometric technology to industry leaders ... their highly accurate, clinically validated, biometric wearable products. These ... January 6-9 in Las Vegas . ... the technology is accurate, flexible and robust – with ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... Robert Linhardt has spent years stitching together minuscule carbohydrates ... commonly used and controversial blood thinner heparin. At the national ... Linhardt announced that his research team may have accomplished this ... is the largest dose of heparin ever created in the ...
... date for bipolar disorder has implicated machinery involved in the ... in part by the National Institute of Mental Health, part ... the disorder and variation in two genes that make components ... and out of cells, including neurons. "A neuron,s ...
... CHAMPAIGN, Ill. Understanding the form and function ... becoming faster and easier, thanks to the work ... combining custom-built spectrometers, novel probe designs and faster ... professor Chad Rienstra has developed unique capabilities for ...
Cached Biology News:Researchers create safer alternative to heparin 2Largest study of its kind implicates gene abnormalities in bipolar disorder 2Improved technique determines structure in membrane proteins 2
... mobility shift assay (EMSA) is a powerful ... to as gel shift or gel retardation, ... that when subjected to electrophoresis, free DNA ... The Pierce LightShift Chemiluminescent EMSA Kit is ...
... The Cell Lab Quantas unique ... provides unsurpassed population resolution capabilities and ... has multiple excitation wavelengths, including UV, ... variety of multi-color applications typically only ...
... Kit delivers a novel procedure for the ... of whole genome DNA from small samples. ... a quick and highly reproducible amplification and ... of a REPLI-g Mini Kit module (QIAGEN) ...
... be superior to transfection in some applications. ... PULSin you can study lethal proteins and ... proteins in cells. Likewise, delivery of blocking ... RNA interference experiments. ,With PULSin you ...
Biology Products: